Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions

Abstract

Regulatory T cells (Tregs) are central to the maintenance of self-tolerance and tissue homeostasis. Markers commonly used to define human Tregs in the research setting include high expression of CD25, FOXP3 positivity and low expression/negativity for CD127. Many other markers have been proposed, but none unequivocally identifies bona fide Tregs. Tregs are equipped with an array of mechanisms of suppression, including the modulation of antigen presenting cell maturation and function, the killing of target cells, the disruption of metabolic pathways and the production of anti-inflammatory cytokines. Treg impairment has been reported in a number of human autoimmune conditions and includes Treg numerical and functional defects and conversion into effector cells in response to inflammation. In addition to intrinsic Treg impairment, resistance of effector T cells to Treg control has been described. Discrepancies in the literature are common, reflecting differences in the choice of study participants and the technical challenges associated with investigating this cell population. Studies differ in terms of the methodology used to define and isolate putative regulatory cells and to assess their suppressive function. In this review we outline studies describing Treg frequency and suppressive function in systemic and organ specific autoimmune diseases, with a specific focus on the challenges faced when investigating Tregs in these conditions.

Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model

“…Beyond the unbalance between T-helper 1 (Th1) and Th2 cell responses, known as part of the IBD aetiology, it is believed that failures in the mediation of regulatory immune response are also involved in this process (Himmel et al, 2008). This idea is supported by some evidence that indicates a key role of FoxP3 in intestinal homeostasis (Himmel et al, 2008;Atarashi et al, 2013;Geem et al, 2015) and its role in reducing colitis severity (Rudensky, 2011;Grant et al, 2015;Raphael et al, 2015;Wang et al, 2015). Powrie et al (1993) conducted a trial assay with immunedeficient mice in which the transfer of naïve CD4 + T-cells in the absence of T reg cells resulted in colitis dependent on the presence of commensal bacteria.…”

IgG4-related sclerosing cholangitis: all we need to know

“…This is another reason why ISC is considered to be a non-autoimmune disease because the functions of this subset of immunesuppressive T cells are generally decreased in classic autoimmune disorders [110,111]. Histologically, a large number of FOXP3?…”

mRNA-based dendritic cell immunization improves survival inrettransgenic mouse melanoma model

“…29 Moreover, these cells may hamper an effective antitumor immune response in cancer patients and tumor-bearing mice.…”